oral mucositis

Galera Lays Off 70% of Staff After FDA Rejection in Severe Oral Mucositis
BioSpace
Thu, 08/10/23 - 11:32 am
Galera Therapeutics
avasopasem manganese
layoffs
oral mucositis
head and neck cancer
FDA
Eyeing untapped niche, EpicentRx makes case for cancer toxicity prevention drug
Fierce Biotech
Fri, 01/20/23 - 10:40 am
EpicentRx
clinical trials
head and neck cancer
oral mucositis
RRx-001
Galera's stock plunges 73% on disappointing test results for lead cancer drug candidate
Bizjournals
Tue, 10/19/21 - 10:53 am
Galera Therapeutics
cancer
clinical trials
head and neck cancer
oral mucositis
GC4419
Monopar raises IPO Target to $46 Million
CP Wire
Wed, 09/11/19 - 09:57 am
Monopar Therapeutics
Validive
severe oral mucositis
oral mucositis
IPOs
Monopar raises IPO Target to $46 Million
Wed, 09/11/19 - 09:53 am
Monopar Therapeutics
Validive
severe oral mucositis
oral mucositis
IPOs
Innovation Provides Update on Ph II Trial of Brilacidin for Severe Oral Mucositis in Head and Neck Cancer
CP Wire
Wed, 05/9/18 - 09:56 am
Innovation Pharmaceuticals
Brilacidin-OM
clinical trials
oral mucositis
Innovation Provides Update on Ph II Trial of Brilacidin for Severe Oral Mucositis in Head and Neck Cancer
Wed, 05/9/18 - 09:43 am
Innovation Pharmaceuticals
Brilacidin
oral mucositis
severe oral mucositis
CANbridge Receives China FDA Approval for Oral Mucositis Therapy
CP Wire
Thu, 04/26/18 - 10:59 am
CANbridge
China
CFDA
CAN002
oral mucositis
CANbridge Receives China FDA Approval for Oral Mucositis Therapy
Thu, 04/26/18 - 09:12 am
CANbridge
oral mucositis
SciClone Pharmaceuticals halts mid-stage study of potential drug due to poor results
Yahoo/AP
Fri, 03/2/12 - 09:49 am
SciClone
head and neck cancer
SCV-07
oral mucositis
SciClone Presents New Preclinical Data Highlighting Potential Role of SCV-07 in Cancer Treatment at 2011 ASCO Annual Meeting
MarketWire
Sun, 06/5/11 - 10:22 am
SciClone
SCV-07
cancer
oral mucositis